central aim of Sussex Health Outcomes, Research & Education in Cancer (SHORE-C) is
to conduct pragmatic research in psychosocial oncology.
Our work includes helping improve the communication skills of members
of cancer teams, developing and evaluating patient interventions, producing
educational training materials and measuring quality of life in clinical
trials of cancer therapy.
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
SHORE-C took part in fundraising event for Rockinghorse children's charity
Brighton & Sussex Medical School reports on SHORE-C's PrefHer study findings
Lesley Fallowfield elected as British Breast Group Chair
HER2-positive breast cancer patients prefer faster subcutaneous administration of Herceptin® (trastuzumab) to IV
UPDATED DVD "COMMUNICATING ABOUT RCTS"
Module 1 of the series “Communicating about RCTs” has been updated, with new material and Professor Lesley Fallowfield presenting results from relevant research studies.
Communicating About Phase 1 & Phase 2 Trials: Facilitator Handbook
Talking About Randomised Clinical Trials